[1] LUTZ T A. Control of food intake and energy expenditure by amylin-therapeutic implications.[J]. International Journal of Obesity, 2009, 33 Suppl 1: S24-7. DOI:
10.1038/ijo.2009.13[2] A N ROBERTS. Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1989, 86 24: 9662-9666. DOI:
10.1073/pnas.86.24.9662[3] G J COOPER. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1987, 84 23: 8628-8632. DOI:
10.1073/pnas.84.23.8628[4] ISAAC T. YONEMOTO. Amylin Proprotein Processing Generates Progressively More Amyloidogenic Peptides that Initially Sample the Helical State†[J]. Biochemistry Biochemistry, 2008, 47 37: 9900-9910. DOI:
10.1021/bi800828u